https://www.selleckchem.com/pr....oducts/trastuzumab-d
by efforts to incorporate ethical and professional education in undergraduate curricula, and by studies in which new codes of ethics are being implemented.INTRODUCTION To evaluate the efficacy and safety of dulaglutide 0.75 and 1.5 mg in patients with type 2 diabetes mellitus (T2DM) by baseline glycated hemoglobin (HbA1c) less then 8.5% or ≥ 8.5% after 26 weeks of treatment. METHODS Assessment of the Weekly AdministRation of dulaglutide in Diabetes (AWARD) China 1 (CHN1) study (NCT01644500, n = 556) included patients on
Like
Comment
Share
